Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Aug 14 2024

Full Issue

CDC Warns Of Surging Fifth Disease

CNN notes that the proportion of people with recent parvovirus B19 infections climbed to 10% in June, and children ages 5 to 9 had the highest increase. Meanwhile, federal officials concerned about rising H5N1 have been testing retail dairy products and haven't found live avian flu virus in any samples.

A seasonal respiratory virus named parvovirus B19 – sometimes also called fifth disease – is increasing in activity, the US Centers for Disease Control and Prevention warned Tuesday. Parvovirus B19 is a common virus spread by respiratory droplets. (Dillinger, 8/13)

On bird flu —

A second round of testing of retail dairy products, which includes more products such as cheese and butter and from a broader geographic area, found no live H5N1 avian flu virus in any of the samples, federal officials said today. The testing included 167 samples from 27 states. (Schnirring, 8/13)

One-in-six dairy products in US retail stores contained signs of inactive bird flu virus this summer, regulators said, slightly lower than the numbers seen in a different survey when the pathogen was first found in the nation’s dairy herds. None of the 167 samples, which included milk, ice cream, hard cheese, butter, cream cheese and aged raw milk cheese, contained viable H5N1 bird flu virus, the US Food and Drug Administration said. The results show pasteurized dairy remains safe to consume. (Vahanvaty, 8/13)

The U.S. Department of Agriculture said on Tuesday it will expand bird-flu testing of beef entering the food supply as part of its response to the ongoing outbreak among dairy cattle, adding that U.S. beef and dairy products remain safe to consume. USDA officials, in a call with reporters along with staff from other U.S. health agencies, said the tests will begin in mid-September and urged livestock workers to remain vigilant. (Douglas, 8/13)

On mpox —

Mpox, the high infectious disease that used to be called monkeypox, has been declared a public health emergency in Africa by the continent’s top health body. Scientists from the Africa Centres for Disease Control and Prevention (Africa CDC) say they are alarmed by the speed at which a new strain of mpox has been spreading. Since the beginning of the year, more than 13,700 cases and 450 deaths have been recorded in the Democratic Republic of Congo. The virus, which can cause lesions across the whole body, has spread to other African countries, including Burundi, the Central African Republic (CAR), Kenya and Rwanda. (Jolaoso, 8/13)

There are two strains of mpox – clade I and clade II. Think of them as two big branches on a tree.Until about five or six years ago these clades weren’t that diverse. Something has changed. These branches are growing and the leaves on the branches are becoming more numerous. In fact, we have new subclades for both I and II, so two new offshoot branches have appeared. Clade II is far less dangerous with a case fatality rate of about 0.1%. In other words, roughly one person in a thousand dies. (Walter, 8/13)

Vaccines to help curb an escalating mpox outbreak in Democratic Republic of Congo and neighbouring countries may still not reach the central African country for months even as the World Health Organization considers following Africa’s top public health agency in declaring the outbreak an emergency. On Tuesday, Africa Centres for Disease Control and Prevention declared a public health emergency of continental concern for the first time ever, and on Wednesday, a WHO-led panel meets to decide if it represents a global threat. (Rigby, 8/14)

Also —

The U.S. Food and Drug Administration has upgraded the recall of about two dozen candies and snacks sold at retailers including Target and Walmart to its highest level of health hazard. Shoppers will want to check their pantries because some of the products – recalled for potential salmonella contamination – have best-by dates into April 2025. (Snider, 8/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ